Sign in

CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6462005278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
  1. 8-K Event Regulation FD disclosure
  2. 8-K Event Results of operations · Other events
  3. 10-Q Report Quarterly Report
  4. 8-K Event Regulation FD disclosure
  5. 4 Insider Changes in Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 8-K Event Executive or director change · Regulation FD disclosure
  8. 8-K Event Results of operations
  9. 10-Q Report Quarterly Report
  10. 8-K Event Shareholder vote results
  11. S-8 Other Securities Offered to Employees in Benefit Plans
  12. 8-K Event Results of operations
  13. 10-Q Report Quarterly Report
  14. DEFA14A Proxy Proxy Materials
  15. DEF 14A Proxy Proxy Statement
  16. 8-K Event Regulation FD disclosure
  17. 424B5 Offering Prospectus
  18. 8-K Event Material agreement · Other events
  19. 424B5 Offering Prospectus
  20. 8-K Event Material agreement · Other events

Page 10 of 64 · 1,276 filings